The Distribution of Gingival Display and Possible Related Factors Resulting in Gummy Smile

Sponsor
Baskent University (Other)
Overall Status
Completed
CT.gov ID
NCT04553952
Collaborator
(none)
501
1
4.4
113.8

Study Details

Study Description

Brief Summary

This study primarily aimed to evaluate smile line distribution and prevalence of gummy smile in patients. The secondary purpose was to examine parameters that might be risk factors for gummy smile.

Condition or Disease Intervention/Treatment Phase
  • Other: Measurement of gingival display

Detailed Description

this study primarily aimed to evaluate smile line distribution and prevalence of gummy smile in patients. The secondary purpose was to examine parameters that might be risk factors for gummy smile.Age, gender, marital status, medical history, and medication status of the patients were recorded. All individuals were instructed to sit on a dental chair and the measurments were made by using a millimetric ruler.Next, the patients were grouped according to Liebart's classification by gingival display at maximum smile as follows: Class 1.Excessive gingival display (Gummy smile): ≥ 3mm gingival display Class 2.High smile line: 0-2 mm of gingival display Class 3. Average smile line: Dental papilla is visible. Class 4. Low smile line: Gingival margin, dental papilla is not visible at all. Presence of altered passive eruption, short lip and hypermobile upper lip were also evaluated.

Study Design

Study Type:
Observational
Actual Enrollment :
501 participants
Official Title:
Evaluating the Distribution of Gingival Display and Possible Related Factors Resulting in Gummy Smile
Actual Study Start Date :
Nov 9, 2019
Actual Primary Completion Date :
Feb 24, 2020
Actual Study Completion Date :
Mar 22, 2020

Arms and Interventions

Arm Intervention/Treatment
Gummy smile (GS(+))

Other: Measurement of gingival display
All individuals were instructed to sit on a dental chair and the measurements were made by using a millimetric ruler. Next, the patients were grouped according to Liebart's classification by gingival display at maximum smile as follows: Class 1.Excessive gingival display (Gummy smile): ≥ 3mm gingival display Class 2.High smile line: 0-2 mm of gingival display Class 3. Average smile line: Dental papilla is visible. Class 4. Low smile line: Gingival margin, dental papilla is not visible at all.

Gumms smile(GS(-))

Other: Measurement of gingival display
All individuals were instructed to sit on a dental chair and the measurements were made by using a millimetric ruler. Next, the patients were grouped according to Liebart's classification by gingival display at maximum smile as follows: Class 1.Excessive gingival display (Gummy smile): ≥ 3mm gingival display Class 2.High smile line: 0-2 mm of gingival display Class 3. Average smile line: Dental papilla is visible. Class 4. Low smile line: Gingival margin, dental papilla is not visible at all.

Outcome Measures

Primary Outcome Measures

  1. Measurement of gingival display [1 minute]

    All individuals were instructed to sit on a dental chair and the measurments were made by using a millimetric ruler. Next, the patients were grouped according to Liebart's classification by gingival display at maximum smile as follows: Class 1.Excessive gingival display (Gummy smile): ≥ 3mm gingival display Class 2.High smile line: 0-2 mm of gingival display Class 3. Average smile line: Dental papilla is visible. Class 4. Low smile line: Gingival margin, dental papilla is not visible at all.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 61 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • presence of teeth in upper jaw

  • Age between 18-65 years

Exclusion Criteria:
  • Patients who have received and/or are receiving orthodontic treatment and patients who received gummy smile treatment were excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Baskent University,Department of Dentistry Ankara Turkey

Sponsors and Collaborators

  • Baskent University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mehtap Bilgin Çetin, DDS,PhD, Baskent University
ClinicalTrials.gov Identifier:
NCT04553952
Other Study ID Numbers:
  • MBilgin
First Posted:
Sep 18, 2020
Last Update Posted:
Sep 18, 2020
Last Verified:
Sep 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Sep 18, 2020